• Ocular Therapeutix Announces Completion of Debt Refinancing biospectrumasia
    January 02, 2019
    The company enters into a $25.0 Million Term Loan with MidCap Financial and Silicon Valley Bank. The 5-year term loan facility allows for an expansion of the Company’s prior $18 million credit facility to $25.0 million, all of which was drawn at closing.
PharmaSources Customer Service